Apotex, Heritage and Breckenridge settle with purchasers in generics price-fixing case
By Fraiser Kansteiner
3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
By Hailey Konnath
FDA posts a flurry of voluntary drug recalls by Teva, Glenmark, Apotex and VistaPharm
By Joseph Keenan
Apotex buys specialty pharma Searchlight in $500-million-plus move to diversify from generic drugs
By Sean Silcoff
Who Murdered Apotex Pharma Billionaire Barry Sherman and Honey?
By Ari Altstedter & Matthew Campbell
Apotex Sues to Clear Tradjenta Copy of Boehringer Patent Claims
By Christopher Yasiejko
Federal Court of Appeal “skinny label” case highlights the potential power of the patentee | Insights
By Nicole Mantini, Andrew M Shaughnessy & Amanda Wolczanski
Troubled generics maker Apotex bought by SK Capital
By Kevin Dunleavy
Sam Chun Dang Pharm licenses out Eylea biosimilar to Canadian company in $15 mil. deal
By Marianne Chang
The hits keep coming: Apotex loses 31 drug approvals after FDA cites plants for 'inadequate' controls
By Kyle Blankenship
Apotex admits to generic price fixing, agrees to pay $24M criminal fine
By Eric Sagonowsky
After SK Capital buyout, Apotex yanks 6 batches of glaucoma med on sterility concerns
By Fraiser Kansteiner
Canadian Drugmaker Apotex May Revive Sale Talks and be Worth Billions
By Manuel Baigorri & Michelle Davis
Bayer, Meda sue Apotex over proposed Astepro Allergy generic
By Blake Brittain
Supernus settles patent litigation with Apotex over Oxtellar
By Jonathan Block, MPH
Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs
By Zachary Brennan
Generic Drug Maker Admits to Fixing Prices for Cholesterol Medication (Published 2020)
By Katie Benner
Apotex pulls injectable anticoagulant batches after CMO's syringe mix-up
By Fraiser Kansteiner
Apotex and Strides to merge their Australia businesses to become the country's largest generics player
By Eric Palmer
Doctrine of Equivalents in Lilly v. Apotex
By Dennis Crouch
U.K. cites Apotex plant in India; action comes in midst of probe into death of Apotex founder
By Eric Palmer
Apotex yanks ADHD med after traces of schizophrenia drug turn up in a single lot
By Fraiser Kansteiner
Accused of stealing Teva secrets, Apotex CEO exits abruptly even as founder's death ruled homicide
By Eric Palmer
Apotex recalls some Metformin batches due to possible carcinogen
By Angela Betsaida B. Laguipo
Scilex, Set to Go Public, Sues Apotex to Block ZTlido Copies (1)
By Christopher Yasiejko
Horizon Sues Apotex to Block Early Launch of Pennsaid 2% Copy
By Christopher Yasiejko
Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend
By Arlene Weintraub
Court documents reveal more details about 2017 homicides of Barry and Honey Sherman
By John Lancaster
Apotex Founder Barry Sherman Was Driven, Generous...and Litigious
By Vipal Monga & Jacquie McNish
The top 15 generic drugmakers by 2016 revenue
By Eric Sagonowsky
Murdered billionaire Sherman's Apotex sold to private firm
By Danielle BOCHOVE
Canadian Drugmaker Apotex Is Said to Weigh Sale Amid Interest
By Manuel Baigorri & Vinicy Chan
Apotex Faces Uncertainty After Founder's Mysterious Death
By Vipal Monga & Jacquie McNish